Intercept Pharmaceuticals | SCHULD



Debt Veränderung Datum
Acadia Pharmaceuticals USD 0 0 2025-03
Alnylam Pharmaceuticals USD 1.03B 945K 2025-03
Amarin USD 0 0 2025-03
Amgen USD 57.38B 2.72B 2025-03
Arrowhead Research USD 388.24M 21.18M 2025-03
AstraZeneca USD 31.65B 1.35B 2025-03
Biogen USD 6.3B 2M 2025-03
Bristol-Myers Squibb USD 49.71B 62M 2025-03
Eli Lilly USD 38.52B 4.87B 2025-03
Gilead Sciences USD 26.71B 3.46B 2024-12
GlaxoSmithKline GBP 18.43B 1.45B 2025-03
Incyte USD 37.12M 840K 2025-03
Ionis Pharmaceuticals USD 1.25B 5.23M 2025-03
Moderna USD 745M 683M 2025-03
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 31.26B 828M 2024-12
PTC Therapeutics USD 2.4B 17.29M 2025-03
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Sarepta Therapeutics USD 1.14B 1.16M 2025-03
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



Intercept Pharmaceuticals SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.